Structural Heart > TAVI Portfolio > ACURATE neo Aortic Valve System
Lean TAVI Procedures with ACURATE neo1
Watch Prof. R. Kharbanda (Oxford, UK) discussing how minimalist TAVI with ACURATE neo results in fewer instances of damage to the conduction system, reduced need for permanent pacemaker and subsequently leads to early discharge which he highlights is “good for the patients and good for the families as well”.
|
TAVI Program Efficiency
Lean procedures with low complication rates enable safe, early discharge and optimized hospital resources.1
45%
Patients Discharged within 2 Days1
with
ACURATE neo
vs 31% with Evolut R
Download data
Length of Stay (LoS)
60%
Safe Next Day Discharge2
with
ACURATE neo
vs 55% with Sapien 3
Procedural Efficiency3
Predictable Deployment and Hemodynamic Stability
The unique, Predictable Top-down Deployment ensures efficiency by providing hemodynamic stability and precise placement during deployment.
Preserved Coronary Perfusion & Future Access
Unique valve design with upper crowns and large open stabilization arches provide coronary clearance and preserved access for future interventions.
PROGRESS PVL
Low, core-lab adjudicated PVL rates and Excellent Hemodynamic Performance4
Low moderate or greater PVL Rates that improved through 1 year
PVL, Paired Analysis
(N = 209, core-lab adjudicated)
Excellent Hemodynamic Performance
Hemodynamic Performance
(mmHg/cm2, core-lab adjudicated)
Strong VARC-2 Clinical Outcomes
